Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Dual Antithrombotic Therapy With Dabigatran
Author(s): Christopher P Cannon Added: 6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation (REDUAL-PCI). Filmed by Radcliffe Cardiology on-site at ESC 2017. View more

Anticoagulation
Antithrombotic Therapy after Percutaneous Coronary Intervention
Author(s): Darshni Arishta Jhagroe , Jur ten Berg Added: 3 years ago
Dual antiplatelet therapy (DAPT) is indicated in patients who need to undergo percutaneous coronary intervention (PCI) procedures.1 Compared with oral anticoagulation (OAC) and aspirin, DAPT has been shown to reduce the risk of thrombotic events and the rate of bleeding events.2 Chronic OAC is required in up to 10 % of the patients undergoing PCI, and is usually indicated for AF and mechanical… View more

Anticoagulation

Intervention
Author(s): Gabriele Pesarini , Sara Ariotti , Flavio Ribichini Added: 3 years ago
Haemostasis is a complex phenomenon defined as the chain of mechanisms able to maintain the integrity of a closed, high-pressure circulatory system after vascular damage.1 Thrombogenesis represents the main process assuring haemostasis at each level of the vascular system, and its accurate regulation guarantees the correct balance between blood flow and damage repair. An uncontrolled thrombin… View more

MI/ACS

Intervention
Author(s): Andrew Archbold Added: 3 years ago
Patients who undergo coronary artery stenting require dual antiplatelet therapy (DAPT) in order to reduce their risk of stent thrombosis. Long-term oral anticoagulation (OAC) is indicated for the primary and secondary prevention of thrombotic events in patients with atrial fibrillation (AF), mechanical heart valves, intra-cardiac thrombus, venous thromboembolic disease and some hypercoagulable… View more

Anticoagulation

Prevention & Chronic Conditions
Antithrombotic Therapy in AF-PCI Patients
Author(s): Antonio Greco , Claudio Laudani , Carla Rochira , et al Added: 1 year ago

Anticoagulation

Intervention
Individualising Antithrombotic Strategies for Established CAD
Author(s): Marco Valgimigli , Eliano Navarese , Pascal Vranckx Added: 1 year ago
This three-part programme delves into the critical importance of individualised antithrombotic treatment in both Acute Coronary Syndrome (ACS) and Chronic Coronary Syndrome (CCS). Part one of this programme presents two compelling patient case studies.Prof Pascal Vranckx (Hartcentrum Hasselt, BE) presents a complex 62-year old male with stable angina and HFrEF, undergoing an elective… View more

Anticoagulation

MI/ACS
Individualising Antithrombotic Strategies for Established CAD
Author(s): Marco Valgimigli , Vijay Kunadian , Pascal Vranckx , et al Start date: Feb 22, 2023

Prevention & Chronic Conditions

Intervention
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI
Author(s): George D Dangas Added: 2 years ago
In this short video, Dr George Dangas (Mount Sinai Hospital, New York, NY, US) shares the findings from the ENVISAGE-TAVI AF hot line trial presented at ESC Congress 2021. ENVISAGE-TAVI AF (Daiichi-Sankyo) compared the safety and efficacy of the DOAC edoxaban with VKAs (warfarin and its analogues) in atrial fibrillation patients with an indication for oral anticoagulation after successful TAVI. … View more

Anticoagulation

Electrophysiology & Arrhythmia
Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Author(s): Antonio Greco , Davide Capodanno Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is a valuable treatment option for patients with severe symptomatic aortic stenosis.1 Its use is supported by the results of multiple randomised controlled trials (RCTs) exploring the entire surgical risk spectrum, including inoperable, high-risk, intermediate risk and low risk patients.2–8 TAVI is associated with a small but not negligible… View more

Vascular Disease and Surgery

Intervention